Business Assets for Sale

Site with high-quality natural mineral water source. - Water is tested and certified for consumption. - The site is located near a highway and is 80 km from Belgrade, Serbia. - All the required environmental clearances are in place. - No need for any chemical treatment for consuming this water. - Water can be sourced from the site at 4 lt. / s. Ph 7.6.

We are looking to sell a commercial land of 6,000 Sq Mt and a warehouse of 2,500 Sq Mt which is owned by us. - The land and warehouse were earlier used as wood factory however, the same can be used for any the manufacturing unit. - It's located next to an airport with great commute and road facilities. - Warehouse is in good condition and best suited for stocking any type of product.

Non-operational refinery setup located in Kuwait available for full sale, offering significant investment potential for buyers in the oil and gas sector. - The refinery's tangible assets include processing units for LPG, naphtha, kerosene, gas oil (diesel), and fuel oil. - Additional infrastructure includes storage tanks and supporting utilities, making it a comprehensive asset for prospective buyers. - Buyers will need to relocate the physical assets as the refinery is dismantled; however, they have the flexibility to set it up anywhere globally. - The sale does not include any licenses, permits, or certifications, which the buyer must obtain independently. - This asset was previously acquired from a petroleum company with the intention of resale, creating a prime opportunity for investors looking to enter or expand in the refining market. - There are no outstanding loans or liabilities on the asset, making it an attractive investment with clean financial standing.

Selling a GMP pharmaceutical manufacturing unit in Dholpur. - The unit has 50 machines for manufacturing / producing various tablets, capsules, syrups and dry syrup. - Each machine has the capacity of producing 2 - 5 Lakh tablets (depending on size) in an 8 hour shift. - The property was taken on lease which has expired a month ago. New buyer would need to renew the lease agreement. - The land has an area of 10,000 Sq. Ft. - Only the manufacturing unit will be sold and not the entire company.

Located in New Hampshire, the company is currently in an updated version with a patent pending. The original version established over USD 2.5 M in sales focused on preventing substance abuse among children and families. - The business was created to address one of the most critical and unmet public health needs: the high risk of drug use beginning in childhood. - The company offers a laboratory-based home drug testing system, developed specifically to empower parents with an effective, anonymous, and preventive solution to identify early drug exposure in children. - This product is the first and only of its kind to receive U. S. FDA premarket approval at the PMA Level III, the highest regulatory standard for medical devices. It is also approved by the UK Medical Device Agency (MDA). - Unlike traditional drug testing solutions, the system is designed for home use while maintaining laboratory-grade accuracy, making it a unique plug-and-play acquisition opportunity for clinical and medical laboratories. - The product demonstrated strong commercial viability 28 years ago, generating over USD 2.5 million in sales revenue. - Due to the founder’s health, the product remained commercially dormant for several years despite its proven market demand and financial success. - In recent years, drug-related dangers and fatalities, particularly among youth and first-time users exposed to substances such as fentanyl, have increased significantly. - In response, the product underwent substantial revisions and was restructured into an LLC to enhance commercial scalability and operational readiness. - The system now directly addresses unmet medical and public health needs affecting over 73 million children and their families, positioning it as a critical preventive tool in today’s substance abuse landscape. - The product’s consumer market is global, with projected revenues in the billions of dollars. Results remain anonymous, increasing consumer adoption and trust. - Clinical laboratories and retail outlets are ideally positioned independently or in collaboration to rapidly capture a significant share of the consumer diagnostics market without incurring substantial risk. - By offering this FDA- and UK MDA-approved testing system, partners gain immediate access to a new, high-margin revenue stream. - The product is fully developed and ready for immediate commercialization, providing acquirers or partners with a rare opportunity to enter a $2+ billion consumer diagnostics market with the only FDA-approved laboratory-based home drug testing system of its kind.